Pharmaceutical Investing Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance 04 November
Pharmaceutical Investing Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition 31 October
